Amryt Pharma Share Discussion Threads

[hotaimstocks] 15/10/2021 11:17

this was 75p last year.... expensive now

[bazworth] 11/10/2021 10:50

"Now covered by Funky Finance"

Worth a listen but if you have been invested here for a little time there is nothing new. Very well presented though.

Hang on tight!!

[mower] 11/10/2021 09:33

Now covered by Funky Finance.Expect things to get a little busier here.https://youtu.be/qS1RKrL2A9c

[papillon] 08/10/2021 22:26

Well AMYT closed at $12 on Nasdaq, but the "after hours" price was $12.45.

[papillon] 08/10/2021 17:34

No problem Anil. Currently a tad below $12 on Nasdaq @ 11.96. Heaven knows why someone bought at 12.91 pre market. Very strange.

[anil157] 08/10/2021 16:36

Many thanks Papillon.

[papillon] 08/10/2021 15:07

There is no disparity, Anil157, since AMYT didn't open higher on Nasdaq. That higher pre Market price that someone bought at was obviously an aberration by the buyer.

[anil157] 08/10/2021 14:18

Why the disparity?

[papillon] 08/10/2021 13:11

Might not mean anything, but AMYT pre market price on Nasdaq is up over 7% @ 12.91.

[papillon] 07/10/2021 22:07

Good find, Bermudashorts.

[bermudashorts] 07/10/2021 15:47

Really interesting research here from Prof. Hebebrand, University of Duisburg-Essen - to be presented at a conference tomorrow.

Based on the fact that the hormone leptin is the major endocrine signal for starvation, he prescribed Amryt's Metreleptin (MYalept/Myalepta) off-label to 11 patients suffering from Anerexia Nervosa with what appear to be very exciting results:-

'We observed a rapid onset of beneficial effects on AN specific cognitions, emotions and behaviors.'

'The seemingly strong psychopharmacological effects of metreleptin warrant further investigation.'

Clearly clinical trials are required but would be fantastic if Metreleptin has a role to play in helping patients battle AN.

[mcfly79] 07/10/2021 10:37

The forecasts have been updated post merger. This is where the $305m revenue forecast is coming from.Paul Hill mentioned a 6x EBITDA multiple for the combined business in 2022. I'm not sure where he's getting the EBITDA figure though.

[bazworth] 07/10/2021 10:24

I think any such forecast would be incredibly unreliable given the (hopefully) imminent launch of Filsuvez as well as the recent merger.

[mcfly79] 07/10/2021 08:19

Thanks.Does anyone know what the EBITDA forecast is for 2022?

[sidam] 06/10/2021 21:13

Maybe Stiffel, Shore Cap, Cannacord (Us) and maybe Davy. But I do not have them.

[mcfly79] 06/10/2021 19:39

Does anyone know who the most recent broker notes are from?

Unfortunately there's nothing on Research Tree.

I can see stockopedia have 2022 forecasts of $305m revenue and $41m net profit, but I'd like to get hold of the broker note with the detail.

[papillon] 05/10/2021 09:05

Just went to buy some AMYT shares online and couldn't get a live quote. Unusual. I did get them after a wait. Something brewing?

[papillon] 03/10/2021 19:03

A couple of Heikin-Ashi charts that look very promising


free stock charts from uk.advfn.com



free stock charts from uk.advfn.com

[onceaday] 03/10/2021 14:32

58 days until PDUFA and labelling discussions should start soon or have started. The closer we get, the more the chance of success increases because FDA has begun issuing rejection letters several weeks prior to PDUFA where issues arise "that preclude labelling discussions".

[papillon] 03/10/2021 14:02

Looks like we could be starting another leg up, bazworth, so you are probably doing the right thing continuing to hold. I'll post a couple of charts later on. A Nasdaq and an AIM chart.

PS I see that liar, who deletes his posts, mdalos1, is still posting his lies under his new nickname. He's SCUM.

[bazworth] 30/9/2021 17:59

Cracking rollercoaster of a ride on the Nasdaq!! Great fun watching this all moving forwards and extremely happy to hold, despite several years of frustration!!

[delta0091] 29/9/2021 23:27

linkedin.com/jobs/view/rare-disease-specialist-rds-filsuvez%C2%AE-oleogel-s10-at-amryt-pharma-plc-2729693995

[papillon] 28/9/2021 23:04

I don't think the Yanks are fans of AMYT. Down on Nasdaq (though the DOW took a tumble today) on above average volume. The RSI and Heikin-Ashi chart don't look promising!


free stock charts from uk.advfn.com


PS AMYT closed at 176p on AIM, not the 180p, as shown on advfn. The last trade was at 180p for a paltry 56 shares @ 4:35pm. It was a UT trade. Why advfn continue to base the closing price of a share on a small UT trade after the official market close is beyond me. The lse web site shows the closing price as 176p, which is correct.

EDIT. I now see that advfn are now showing the closing price as 176p.

[moorsie2] 23/9/2021 07:39

Yip looks like moving into a upward breakout